Add 2 More Reports For 20% off

Report Overview

The global lancet market size was valued at USD 2.00 Billion in 2023, driven by the increasing availability of a big pool of diabetic patients. The market size is anticipated to grow at a CAGR of 10.60% during the forecast period of 2024-2032 to achieve a value of USD 4.95 Billion by 2032.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Compound Annual Growth Rate

Value in USD Billion

10.6%

2024-2032


Lancet Market Outlook

*this image is indicative*

Lancets Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Lancet Market Overview

The lancet is a small medical implement used to prick the skin, particularly for blood sugar monitoring or capillary blood sampling. The growth of the lancet market can be attributed to the availability of a big pool of diabetic patients and the growing incidences of infectious diseases requiring blood testing for diagnosis and therapy, along with increased awareness of diabetes treatment globally.

Rising Prevalence of Diabetes and High Cholesterol

The increasing issue of high cholesterol among people, especially the geriatric population, is contributing to the global lancet market demand. It is estimated that high cholesterol causes 4.4 million deaths every year. It is a major risk factor for heart disease and stroke in both high- and low-income countries. Practices such as consuming a healthy diet, regular exercise, and medication can help reduce high cholesterol.

In June 2023, according to data from the Institute for Health and Metrics Evaluation, over 500 million people across the globe are currently living with diabetes. This chronic disease affects individuals of all ages and genders in every country worldwide. Unfortunately, this number is projected to more than double in the next 30 years, with estimates suggesting that 1.3 billion people will be living with diabetes by then. This increase is expected to be experienced in every country, highlighting the urgent need for effective prevention and management strategies.

The high prevalence of such conditions requires regular checkups so that they can be diagnosed early and treated well. The lancet are used in the devices that are used to diagnose these conditions through blood sampling such as cholesterol testing devices.

Increased Product Launches in the Market

In August 2023, Roche Diabetes Care Japan Co., Ltd. announced the launch of Accu-Chek Pico, a handy and fully disposable lancet device for blood glucose monitoring to enhance diabetes care for older people living with diabetes nationwide. Accu-Chek Pico will be available in medical institutions such as hospitals and retail pharmacies across Japan.

This innovative product, designed for older people with diabetes is poised to enhance diabetes care. Further, the availability in medical institutions and retail pharmacies throughout Japan for this product is expected to potentially increase demand for lancet in the region, bolstering the lancet market growth.

Additionally, in January 2024, Dexcom revealed new details about Stelo, its new continuous glucose monitor (CGM) designed for people with diabetes who do not take insulin. Stelo by Dexcom, a new continuous glucose monitor targeted for people with diabetes who are not on insulin, has been submitted to the FDA. The medical equipment manufacturer also shared updates on the unique features of the wearable, pricing, and the planned rollout timeline for the device. Stelo launch is expected this summer of 2024 if approved successfully.

This may impact the lancet market potentially by reducing the demand for traditional blood glucose monitoring using lancet. CGMs like Stelo offer continuous monitoring without the need for frequent fingerstick tests which may potentially lead to a shift in user preferences and impact the market for lancet used in traditional blood glucose meters.

Rapid Improvements to Provide a Significant Push

In November 2023, Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus on lung disease, announced the validation and launch of a new method of collecting blood specimens for Nodify Lung Nodule Risk Assessment testing. The method uses the FDA-cleared Tasso+™ device, a single-use blood lancing device intended for obtaining capillary whole blood samples from a patient’s upper arm.

The integration of innovative devices like Tasso+™ signals potential growth, as it introduces an efficient and patient-friendly alternative for fetching blood samples, potentially influencing increased adoption and demand in the lancet market.

Increase in FDA Approvals

In October 2023, Sanguina received the approval from the US Food and Drug Administration (FDA) for its haemoglobin test kit, AnemoCheck Home. AnemoCheck Home, which is an in vitro diagnostic device, will be available only through prescription. Sanguina’s disposable test helps users receive precise haemoglobin level readings by carrying out a simple fingerstick blood test. Sanguina is focused on the development of digital and at-home health platforms for quick home-based testing and disease management. The brand is excited to provide a convenient, accurate, and accessible tool to monitor their haemoglobin levels at home. This approval would significantly aid the global lancet market demand as the test requires a simple fingerstick blood sample, propelling the demand for lancets used in home-based testing and aligning with the growing trend of at-home health monitoring and disease management. Globally, around 40% of all children aged 6–59 months, 37% of pregnant women, and 30% of women 15–49 years of age are affected by anaemia.

Lancets Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Lancet Market Segmentations

Market Breakup by Type

  • Safety Lancet
    • Side Button Lancet
    • Push Button Safety Lancet
    • Pressure Activated Safety Lancet
  • Personal Lancet

Market Breakup by Applications

  • Hemoglobin Testing
  • Glucose Testing
  • Coagulation Testing
  • Others

Market Breakup by End User

  • Hospitals and Clinics
  • Diagnostics Centers and Pathology Laboratories
  • Home Diagnostics
  • Research and Academic Laboratories

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Lancets Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF 

Global Lancet Market Regional Analysis

The growth of the market is primarily driven by the increasing incidences of diabetes and high infectious diseases worldwide. However, the danger of needlestick injuries, the reuse of lancets, and the bad reimbursement situation may act as the major market constraints, hampering the lancet market growth.

North America is anticipated to dominate the regional market due to factors such as the increasing healthcare sector, increasing geriatric population, fast financial development, and increased awareness of diabetes treatment are some of the primary factors, which are aiding in the growth of the North America lancet market growth.

In January 2023, Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions. Another addition to its product offerings for diagnostics laboratories, Cipla’s device named Cippoint, offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is approved by the European In-Vitro Diagnostic Device Directive, thus ensuring reliable testing solutions.

Cippoint – an immunofluorescence-based quantitative analyser, can help healthcare professionals to get test results in 3 to 15 minutes, thus enabling a faster clinical decision-making process.

The introduction of Cipla's point-of-care testing device could increase the demand for lancets as they are commonly used in devices for blood sampling in point-of-care diagnostics, bolstering the market demand. The focus of Cippoint on accessibility in rural and remote areas is further expected to drive the need for lancets in healthcare settings.

Global Lancet Market: Competitor Landscape

In December 2023, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced it had received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Terumo Corporation
  • Bayer AG
  • MTD Medical Technology and Devices
  • Sarstedt AG & Co. KG
  • BD
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Greiner Bio-One International GmbH
  • Improve Medical
  • B. Braun SE
  • Medline Industries, Inc.
  • Nipro Medical Corporation
  • Owen Mumford
  • ARKRAY, Inc.
  • Bionime Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 2.00 Billion in 2023, driven by the increasing prevalence of diabetes and anemia.

The market is anticipated to grow at a CAGR of 10.60% during the forecast period of 2024-2032 and is likely to reach a market value of USD 4.95 Billion by 2032.

Factors such as the increasing prevalence of anemia, high cholesterol, and diabetes among people, market expansion with product launches, and technological advancements are among the major factors driving the market demand.

The increasing number of FDA clearances for new devices is a major trend influencing the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The types of lancets can be divided into side button lancets and personal lancet. Side button lancets can be divided into push button safety lancets, and pressure-activated safety lancet.

Lancets have wide applications in hemoglobin testing, glucose testing, and coagulation testing, among others.

End users in the market are hospitals, clinics, diagnostics centers, pathology laboratories, home diagnostics, research, and academic laboratories.

Key players involved in the market are Terumo Corporation, Bayer AG, MTD Medical Technology and Devices, Sarstedt AG & Co. KG, BD, Abbott, F. Hoffmann-La Roche Ltd., Greiner Bio-One International GmbH, Improve Medical, B. Braun SE, Medline Industries, Inc., Nipro Medical Corporation, Owen Mumford, ARKRAY, Inc., and Bionime Corporation.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Applications
  • End User
  • Region
Breakup by Type
  • Safety Lancet
  • Personal Lancet
Breakup by Applications
  • Hemoglobin Testing 
  • Glucose Testing 
  • Coagulation Testing 
  • Others
Breakup by End User
  • Hospitals and Clinics 
  • Diagnostics Centers and Pathology Laboratories 
  • Home Diagnostics 
  • Research and Academic Laboratories
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Terumo Corporation
  • Bayer AG
  • MTD Medical technology and Devices
  • Sarstedt AG & Co. KG
  • BD
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Greiner Bio-One International GmbH
  • Improve Medical
  • B. Braun SE
  • Medline Industries, Inc.
  • Nipro Medical Corporation
  • Owen Mumford
  • ARKRAY, Inc.
  • Bionime Corporation
 

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124